Oncolytic virotherapy for multiple myeloma

By Stief Amaalia E   McCart J Andrea  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 463-473

Informa Healthcare

Access to resources Recommend Favorite

Arsenic metabolism in multiple myeloma and astrocytoma cells

By Falnoga Ingrid   Šlejkovec Zdenka   Pucer Anja   Podgornik Helena   Tušek-Žnidarič Magda  

Biological Trace Element Research, Vol. 116, Iss. 1, 2007-04 ,pp. : 5-28

Humana Press, Inc

Access to resources Recommend Favorite

Does catalytic activity of bence-jones proteins contribute to the pathogenesis of multiple myeloma?

By Sinohara Hyogo   Matsuura Kinji  

Applied Biochemistry and Biotechnology, Vol. 83, Iss. 1-3, 2000-01 ,pp. : 85-94

Humana Press, Inc

Access to resources Recommend Favorite

Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myeloma

By Lonial Sagar   Kaufman Jonathan   Laubach Jacob   Richardson Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 12, 2013-12 ,pp. : 1731-1740

Informa Healthcare

Access to resources Recommend Favorite

Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma Cells

By Ohtomo T.   Sugamata Y.   Ozaki Y.   Ono K.   Yoshimura Y.   Kawai S.   Koishihara Y.   Ozaki S.   Kosaka M.   Hirano T.   Tsuchiya M.  

Biochemical and Biophysical Research Communications, Vol. 258, Iss. 3, 1999-05 ,pp. : 583-591

Elsevier

Access to resources Recommend Favorite